Global Nocturia Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.

According to our (Global Info Research) latest study, the global Nocturia market size was valued at US$ 2731 million in 2023 and is forecast to a readjusted size of USD 4080 million by 2030 with a CAGR of 5.7% during review period.

The global nocturia market, focused on the treatment of nighttime urination, is growing due to an increasing aging population, rising awareness of urinary disorders, and advancements in treatment options. Below are some key trends driving the market:
1. Growing Aging Population
Primary Driver: Nocturia is more prevalent among the elderly, and with a rapidly aging global population, the demand for nocturia treatments is rising. Regions with older populations, such as Europe, North America, and Japan, are seeing increased incidence rates.

Impact: The increase in elderly individuals with nocturia-related issues is expected to drive the demand for pharmaceutical treatments and non-pharmaceutical interventions.

2. Advancements in Treatment Options
Medications: A range of medications, including anticholinergics, desmopressin, and beta-3 adrenergic receptor agonists, are commonly used to treat nocturia. New drug formulations are being developed to reduce side effects and improve efficacy.

Emerging Therapies: Research into gene therapies and targeted molecular therapies is advancing. Additionally, the combination of medications for better symptom control is being explored.

Non-Pharmacological Treatments: Beyond drugs, lifestyle interventions, such as fluid management, bladder training, and devices like bedwetting alarms, are gaining attention as complementary treatments.

3. Increasing Awareness and Diagnosis
Education: Public health campaigns and awareness programs about nocturia are encouraging individuals to seek medical help. Increased awareness is expected to drive the market as more people seek treatment for the condition.

Early Diagnosis: Enhanced diagnostic tools, including better urodynamic testing and digital health platforms for symptom tracking, are improving early detection and management of nocturia.

4. Regional Growth
North America: The U.S. holds the largest market share due to its advanced healthcare infrastructure, higher awareness, and the presence of major pharmaceutical companies. Increasing cases of nocturia among older adults are a significant market driver.

Europe: Aging populations, particularly in Western Europe, are contributing to the increased demand for nocturia treatments. The market in this region benefits from well-established healthcare systems.

Asia-Pacific: The growing healthcare infrastructure in countries like China, Japan, and India is expected to boost market growth. Rising healthcare expenditure and increasing elderly populations in these regions are key factors.

Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.

This report is a detailed and comprehensive analysis for global Nocturia market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Sale Channels. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Nocturia market size and forecasts, in consumption value ($ Million), 2019-2030
Global Nocturia market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Nocturia market size and forecasts, by Type and by Sale Channels, in consumption value ($ Million), 2019-2030
Global Nocturia market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nocturia
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nocturia market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott, Teva, Mylan, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Nocturia market is split by Type and by Sale Channels. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Sale Channels. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Nocturia market is split by Type and by Sale Channels. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Sale Channels. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Desmopressin
    Anticholinergic Drugs
    Alpha Blockers
    Diuretics
    Others

Market segment by Sale Channels
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Market segment by players, this report covers
    Astellas Pharma
    Allergan
    Ferring Pharmaceuticals
    Eli Lilly
    GlaxoSmithKline
    Sanofi
    Pfizer
    Abbott
    Teva
    Mylan
    Novartis
    Johnson & Johnson
    Merck
    Astra Zeneca
    Bristol-Myers Squibb
    Hainan Zhonghe Pharmaceutical
    Fosun Pharma
    Hybio Pharmaceutical
    Rechon Life Science AB
    Zhejiang Conba Pharmaceutical
    Chengdu Leer Pharmaceutical
    Nanjing Xingyin Pharmaceutical Group
    Sun Pharmaceutical Industries Ltd.
    APOTEX INC
    Sagent Pharmaceuticals

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nocturia product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nocturia, with revenue, gross margin, and global market share of Nocturia from 2019 to 2024.
Chapter 3, the Nocturia competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Sale Channels, with consumption value and growth rate by Type, by Sale Channels, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nocturia market forecast, by regions, by Type and by Sale Channels, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nocturia.
Chapter 13, to describe Nocturia research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Nocturia by Type
        1.3.1 Overview: Global Nocturia Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Nocturia Consumption Value Market Share by Type in 2023
        1.3.3 Desmopressin
        1.3.4 Anticholinergic Drugs
        1.3.5 Alpha Blockers
        1.3.6 Diuretics
        1.3.7 Others
    1.4 Global Nocturia Market by Sale Channels
        1.4.1 Overview: Global Nocturia Market Size by Sale Channels: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
    1.5 Global Nocturia Market Size & Forecast
    1.6 Global Nocturia Market Size and Forecast by Region
        1.6.1 Global Nocturia Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Nocturia Market Size by Region, (2019-2030)
        1.6.3 North America Nocturia Market Size and Prospect (2019-2030)
        1.6.4 Europe Nocturia Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Nocturia Market Size and Prospect (2019-2030)
        1.6.6 South America Nocturia Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Nocturia Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Astellas Pharma
        2.1.1 Astellas Pharma Details
        2.1.2 Astellas Pharma Major Business
        2.1.3 Astellas Pharma Nocturia Product and Solutions
        2.1.4 Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Astellas Pharma Recent Developments and Future Plans
    2.2 Allergan
        2.2.1 Allergan Details
        2.2.2 Allergan Major Business
        2.2.3 Allergan Nocturia Product and Solutions
        2.2.4 Allergan Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Allergan Recent Developments and Future Plans
    2.3 Ferring Pharmaceuticals
        2.3.1 Ferring Pharmaceuticals Details
        2.3.2 Ferring Pharmaceuticals Major Business
        2.3.3 Ferring Pharmaceuticals Nocturia Product and Solutions
        2.3.4 Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Ferring Pharmaceuticals Recent Developments and Future Plans
    2.4 Eli Lilly
        2.4.1 Eli Lilly Details
        2.4.2 Eli Lilly Major Business
        2.4.3 Eli Lilly Nocturia Product and Solutions
        2.4.4 Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Eli Lilly Recent Developments and Future Plans
    2.5 GlaxoSmithKline
        2.5.1 GlaxoSmithKline Details
        2.5.2 GlaxoSmithKline Major Business
        2.5.3 GlaxoSmithKline Nocturia Product and Solutions
        2.5.4 GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 GlaxoSmithKline Recent Developments and Future Plans
    2.6 Sanofi
        2.6.1 Sanofi Details
        2.6.2 Sanofi Major Business
        2.6.3 Sanofi Nocturia Product and Solutions
        2.6.4 Sanofi Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Sanofi Recent Developments and Future Plans
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Nocturia Product and Solutions
        2.7.4 Pfizer Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Pfizer Recent Developments and Future Plans
    2.8 Abbott
        2.8.1 Abbott Details
        2.8.2 Abbott Major Business
        2.8.3 Abbott Nocturia Product and Solutions
        2.8.4 Abbott Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Abbott Recent Developments and Future Plans
    2.9 Teva
        2.9.1 Teva Details
        2.9.2 Teva Major Business
        2.9.3 Teva Nocturia Product and Solutions
        2.9.4 Teva Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Teva Recent Developments and Future Plans
    2.10 Mylan
        2.10.1 Mylan Details
        2.10.2 Mylan Major Business
        2.10.3 Mylan Nocturia Product and Solutions
        2.10.4 Mylan Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Mylan Recent Developments and Future Plans
    2.11 Novartis
        2.11.1 Novartis Details
        2.11.2 Novartis Major Business
        2.11.3 Novartis Nocturia Product and Solutions
        2.11.4 Novartis Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Novartis Recent Developments and Future Plans
    2.12 Johnson & Johnson
        2.12.1 Johnson & Johnson Details
        2.12.2 Johnson & Johnson Major Business
        2.12.3 Johnson & Johnson Nocturia Product and Solutions
        2.12.4 Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Johnson & Johnson Recent Developments and Future Plans
    2.13 Merck
        2.13.1 Merck Details
        2.13.2 Merck Major Business
        2.13.3 Merck Nocturia Product and Solutions
        2.13.4 Merck Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Merck Recent Developments and Future Plans
    2.14 Astra Zeneca
        2.14.1 Astra Zeneca Details
        2.14.2 Astra Zeneca Major Business
        2.14.3 Astra Zeneca Nocturia Product and Solutions
        2.14.4 Astra Zeneca Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Astra Zeneca Recent Developments and Future Plans
    2.15 Bristol-Myers Squibb
        2.15.1 Bristol-Myers Squibb Details
        2.15.2 Bristol-Myers Squibb Major Business
        2.15.3 Bristol-Myers Squibb Nocturia Product and Solutions
        2.15.4 Bristol-Myers Squibb Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.16 Hainan Zhonghe Pharmaceutical
        2.16.1 Hainan Zhonghe Pharmaceutical Details
        2.16.2 Hainan Zhonghe Pharmaceutical Major Business
        2.16.3 Hainan Zhonghe Pharmaceutical Nocturia Product and Solutions
        2.16.4 Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Hainan Zhonghe Pharmaceutical Recent Developments and Future Plans
    2.17 Fosun Pharma
        2.17.1 Fosun Pharma Details
        2.17.2 Fosun Pharma Major Business
        2.17.3 Fosun Pharma Nocturia Product and Solutions
        2.17.4 Fosun Pharma Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Fosun Pharma Recent Developments and Future Plans
    2.18 Hybio Pharmaceutical
        2.18.1 Hybio Pharmaceutical Details
        2.18.2 Hybio Pharmaceutical Major Business
        2.18.3 Hybio Pharmaceutical Nocturia Product and Solutions
        2.18.4 Hybio Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Hybio Pharmaceutical Recent Developments and Future Plans
    2.19 Rechon Life Science AB
        2.19.1 Rechon Life Science AB Details
        2.19.2 Rechon Life Science AB Major Business
        2.19.3 Rechon Life Science AB Nocturia Product and Solutions
        2.19.4 Rechon Life Science AB Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.19.5 Rechon Life Science AB Recent Developments and Future Plans
    2.20 Zhejiang Conba Pharmaceutical
        2.20.1 Zhejiang Conba Pharmaceutical Details
        2.20.2 Zhejiang Conba Pharmaceutical Major Business
        2.20.3 Zhejiang Conba Pharmaceutical Nocturia Product and Solutions
        2.20.4 Zhejiang Conba Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.20.5 Zhejiang Conba Pharmaceutical Recent Developments and Future Plans
    2.21 Chengdu Leer Pharmaceutical
        2.21.1 Chengdu Leer Pharmaceutical Details
        2.21.2 Chengdu Leer Pharmaceutical Major Business
        2.21.3 Chengdu Leer Pharmaceutical Nocturia Product and Solutions
        2.21.4 Chengdu Leer Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.21.5 Chengdu Leer Pharmaceutical Recent Developments and Future Plans
    2.22 Nanjing Xingyin Pharmaceutical Group
        2.22.1 Nanjing Xingyin Pharmaceutical Group Details
        2.22.2 Nanjing Xingyin Pharmaceutical Group Major Business
        2.22.3 Nanjing Xingyin Pharmaceutical Group Nocturia Product and Solutions
        2.22.4 Nanjing Xingyin Pharmaceutical Group Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.22.5 Nanjing Xingyin Pharmaceutical Group Recent Developments and Future Plans
    2.23 Sun Pharmaceutical Industries Ltd.
        2.23.1 Sun Pharmaceutical Industries Ltd. Details
        2.23.2 Sun Pharmaceutical Industries Ltd. Major Business
        2.23.3 Sun Pharmaceutical Industries Ltd. Nocturia Product and Solutions
        2.23.4 Sun Pharmaceutical Industries Ltd. Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.23.5 Sun Pharmaceutical Industries Ltd. Recent Developments and Future Plans
    2.24 APOTEX INC
        2.24.1 APOTEX INC Details
        2.24.2 APOTEX INC Major Business
        2.24.3 APOTEX INC Nocturia Product and Solutions
        2.24.4 APOTEX INC Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.24.5 APOTEX INC Recent Developments and Future Plans
    2.25 Sagent Pharmaceuticals
        2.25.1 Sagent Pharmaceuticals Details
        2.25.2 Sagent Pharmaceuticals Major Business
        2.25.3 Sagent Pharmaceuticals Nocturia Product and Solutions
        2.25.4 Sagent Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        2.25.5 Sagent Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Nocturia Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Nocturia by Company Revenue
        3.2.2 Top 3 Nocturia Players Market Share in 2023
        3.2.3 Top 6 Nocturia Players Market Share in 2023
    3.3 Nocturia Market: Overall Company Footprint Analysis
        3.3.1 Nocturia Market: Region Footprint
        3.3.2 Nocturia Market: Company Product Type Footprint
        3.3.3 Nocturia Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Nocturia Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Nocturia Market Forecast by Type (2025-2030)

5 Market Size Segment by Sale Channels
    5.1 Global Nocturia Consumption Value Market Share by Sale Channels (2019-2024)
    5.2 Global Nocturia Market Forecast by Sale Channels (2025-2030)

6 North America
    6.1 North America Nocturia Consumption Value by Type (2019-2030)
    6.2 North America Nocturia Market Size by Sale Channels (2019-2030)
    6.3 North America Nocturia Market Size by Country
        6.3.1 North America Nocturia Consumption Value by Country (2019-2030)
        6.3.2 United States Nocturia Market Size and Forecast (2019-2030)
        6.3.3 Canada Nocturia Market Size and Forecast (2019-2030)
        6.3.4 Mexico Nocturia Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Nocturia Consumption Value by Type (2019-2030)
    7.2 Europe Nocturia Consumption Value by Sale Channels (2019-2030)
    7.3 Europe Nocturia Market Size by Country
        7.3.1 Europe Nocturia Consumption Value by Country (2019-2030)
        7.3.2 Germany Nocturia Market Size and Forecast (2019-2030)
        7.3.3 France Nocturia Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Nocturia Market Size and Forecast (2019-2030)
        7.3.5 Russia Nocturia Market Size and Forecast (2019-2030)
        7.3.6 Italy Nocturia Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Nocturia Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Nocturia Consumption Value by Sale Channels (2019-2030)
    8.3 Asia-Pacific Nocturia Market Size by Region
        8.3.1 Asia-Pacific Nocturia Consumption Value by Region (2019-2030)
        8.3.2 China Nocturia Market Size and Forecast (2019-2030)
        8.3.3 Japan Nocturia Market Size and Forecast (2019-2030)
        8.3.4 South Korea Nocturia Market Size and Forecast (2019-2030)
        8.3.5 India Nocturia Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Nocturia Market Size and Forecast (2019-2030)
        8.3.7 Australia Nocturia Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Nocturia Consumption Value by Type (2019-2030)
    9.2 South America Nocturia Consumption Value by Sale Channels (2019-2030)
    9.3 South America Nocturia Market Size by Country
        9.3.1 South America Nocturia Consumption Value by Country (2019-2030)
        9.3.2 Brazil Nocturia Market Size and Forecast (2019-2030)
        9.3.3 Argentina Nocturia Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Nocturia Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Nocturia Consumption Value by Sale Channels (2019-2030)
    10.3 Middle East & Africa Nocturia Market Size by Country
        10.3.1 Middle East & Africa Nocturia Consumption Value by Country (2019-2030)
        10.3.2 Turkey Nocturia Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Nocturia Market Size and Forecast (2019-2030)
        10.3.4 UAE Nocturia Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Nocturia Market Drivers
    11.2 Nocturia Market Restraints
    11.3 Nocturia Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Nocturia Industry Chain
    12.2 Nocturia Upstream Analysis
    12.3 Nocturia Midstream Analysis
    12.4 Nocturia Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Nocturia Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Nocturia Consumption Value by Sale Channels, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Nocturia Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Nocturia Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Astellas Pharma Company Information, Head Office, and Major Competitors
 Table 6. Astellas Pharma Major Business
 Table 7. Astellas Pharma Nocturia Product and Solutions
 Table 8. Astellas Pharma Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Astellas Pharma Recent Developments and Future Plans
 Table 10. Allergan Company Information, Head Office, and Major Competitors
 Table 11. Allergan Major Business
 Table 12. Allergan Nocturia Product and Solutions
 Table 13. Allergan Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Allergan Recent Developments and Future Plans
 Table 15. Ferring Pharmaceuticals Company Information, Head Office, and Major Competitors
 Table 16. Ferring Pharmaceuticals Major Business
 Table 17. Ferring Pharmaceuticals Nocturia Product and Solutions
 Table 18. Ferring Pharmaceuticals Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. Eli Lilly Company Information, Head Office, and Major Competitors
 Table 20. Eli Lilly Major Business
 Table 21. Eli Lilly Nocturia Product and Solutions
 Table 22. Eli Lilly Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. Eli Lilly Recent Developments and Future Plans
 Table 24. GlaxoSmithKline Company Information, Head Office, and Major Competitors
 Table 25. GlaxoSmithKline Major Business
 Table 26. GlaxoSmithKline Nocturia Product and Solutions
 Table 27. GlaxoSmithKline Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. GlaxoSmithKline Recent Developments and Future Plans
 Table 29. Sanofi Company Information, Head Office, and Major Competitors
 Table 30. Sanofi Major Business
 Table 31. Sanofi Nocturia Product and Solutions
 Table 32. Sanofi Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. Sanofi Recent Developments and Future Plans
 Table 34. Pfizer Company Information, Head Office, and Major Competitors
 Table 35. Pfizer Major Business
 Table 36. Pfizer Nocturia Product and Solutions
 Table 37. Pfizer Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. Pfizer Recent Developments and Future Plans
 Table 39. Abbott Company Information, Head Office, and Major Competitors
 Table 40. Abbott Major Business
 Table 41. Abbott Nocturia Product and Solutions
 Table 42. Abbott Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. Abbott Recent Developments and Future Plans
 Table 44. Teva Company Information, Head Office, and Major Competitors
 Table 45. Teva Major Business
 Table 46. Teva Nocturia Product and Solutions
 Table 47. Teva Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 48. Teva Recent Developments and Future Plans
 Table 49. Mylan Company Information, Head Office, and Major Competitors
 Table 50. Mylan Major Business
 Table 51. Mylan Nocturia Product and Solutions
 Table 52. Mylan Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 53. Mylan Recent Developments and Future Plans
 Table 54. Novartis Company Information, Head Office, and Major Competitors
 Table 55. Novartis Major Business
 Table 56. Novartis Nocturia Product and Solutions
 Table 57. Novartis Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 58. Novartis Recent Developments and Future Plans
 Table 59. Johnson & Johnson Company Information, Head Office, and Major Competitors
 Table 60. Johnson & Johnson Major Business
 Table 61. Johnson & Johnson Nocturia Product and Solutions
 Table 62. Johnson & Johnson Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 63. Johnson & Johnson Recent Developments and Future Plans
 Table 64. Merck Company Information, Head Office, and Major Competitors
 Table 65. Merck Major Business
 Table 66. Merck Nocturia Product and Solutions
 Table 67. Merck Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 68. Merck Recent Developments and Future Plans
 Table 69. Astra Zeneca Company Information, Head Office, and Major Competitors
 Table 70. Astra Zeneca Major Business
 Table 71. Astra Zeneca Nocturia Product and Solutions
 Table 72. Astra Zeneca Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 73. Astra Zeneca Recent Developments and Future Plans
 Table 74. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
 Table 75. Bristol-Myers Squibb Major Business
 Table 76. Bristol-Myers Squibb Nocturia Product and Solutions
 Table 77. Bristol-Myers Squibb Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 78. Bristol-Myers Squibb Recent Developments and Future Plans
 Table 79. Hainan Zhonghe Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 80. Hainan Zhonghe Pharmaceutical Major Business
 Table 81. Hainan Zhonghe Pharmaceutical Nocturia Product and Solutions
 Table 82. Hainan Zhonghe Pharmaceutical Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Hainan Zhonghe Pharmaceutical Recent Developments and Future Plans
 Table 84. Fosun Pharma Company Information, Head Office, and Major Competitors
 Table 85. Fosun Pharma Major Business
 Table 86. Fosun Pharma Nocturia Product and Solutions
 Table 87. Fosun Pharma Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 88. Fosun Pharma Recent Developments and Future Plans
 Table 89. Hybio Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 90. Hybio Pharmaceutical Major Business
 Table 91. Hybio Pharmaceutical Nocturia Product and Solutions
 Table 92. Hybio Pharmaceutical Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 93. Hybio Pharmaceutical Recent Developments and Future Plans
 Table 94. Rechon Life Science AB Company Information, Head Office, and Major Competitors
 Table 95. Rechon Life Science AB Major Business
 Table 96. Rechon Life Science AB Nocturia Product and Solutions
 Table 97. Rechon Life Science AB Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 98. Rechon Life Science AB Recent Developments and Future Plans
 Table 99. Zhejiang Conba Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 100. Zhejiang Conba Pharmaceutical Major Business
 Table 101. Zhejiang Conba Pharmaceutical Nocturia Product and Solutions
 Table 102. Zhejiang Conba Pharmaceutical Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 103. Zhejiang Conba Pharmaceutical Recent Developments and Future Plans
 Table 104. Chengdu Leer Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 105. Chengdu Leer Pharmaceutical Major Business
 Table 106. Chengdu Leer Pharmaceutical Nocturia Product and Solutions
 Table 107. Chengdu Leer Pharmaceutical Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 108. Chengdu Leer Pharmaceutical Recent Developments and Future Plans
 Table 109. Nanjing Xingyin Pharmaceutical Group Company Information, Head Office, and Major Competitors
 Table 110. Nanjing Xingyin Pharmaceutical Group Major Business
 Table 111. Nanjing Xingyin Pharmaceutical Group Nocturia Product and Solutions
 Table 112. Nanjing Xingyin Pharmaceutical Group Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Nanjing Xingyin Pharmaceutical Group Recent Developments and Future Plans
 Table 114. Sun Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
 Table 115. Sun Pharmaceutical Industries Ltd. Major Business
 Table 116. Sun Pharmaceutical Industries Ltd. Nocturia Product and Solutions
 Table 117. Sun Pharmaceutical Industries Ltd. Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 118. Sun Pharmaceutical Industries Ltd. Recent Developments and Future Plans
 Table 119. APOTEX INC Company Information, Head Office, and Major Competitors
 Table 120. APOTEX INC Major Business
 Table 121. APOTEX INC Nocturia Product and Solutions
 Table 122. APOTEX INC Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 123. APOTEX INC Recent Developments and Future Plans
 Table 124. Sagent Pharmaceuticals Company Information, Head Office, and Major Competitors
 Table 125. Sagent Pharmaceuticals Major Business
 Table 126. Sagent Pharmaceuticals Nocturia Product and Solutions
 Table 127. Sagent Pharmaceuticals Nocturia Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 128. Sagent Pharmaceuticals Recent Developments and Future Plans
 Table 129. Global Nocturia Revenue (USD Million) by Players (2019-2024)
 Table 130. Global Nocturia Revenue Share by Players (2019-2024)
 Table 131. Breakdown of Nocturia by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 132. Market Position of Players in Nocturia, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 133. Head Office of Key Nocturia Players
 Table 134. Nocturia Market: Company Product Type Footprint
 Table 135. Nocturia Market: Company Product Application Footprint
 Table 136. Nocturia New Market Entrants and Barriers to Market Entry
 Table 137. Nocturia Mergers, Acquisition, Agreements, and Collaborations
 Table 138. Global Nocturia Consumption Value (USD Million) by Type (2019-2024)
 Table 139. Global Nocturia Consumption Value Share by Type (2019-2024)
 Table 140. Global Nocturia Consumption Value Forecast by Type (2025-2030)
 Table 141. Global Nocturia Consumption Value by Sale Channels (2019-2024)
 Table 142. Global Nocturia Consumption Value Forecast by Sale Channels (2025-2030)
 Table 143. North America Nocturia Consumption Value by Type (2019-2024) & (USD Million)
 Table 144. North America Nocturia Consumption Value by Type (2025-2030) & (USD Million)
 Table 145. North America Nocturia Consumption Value by Sale Channels (2019-2024) & (USD Million)
 Table 146. North America Nocturia Consumption Value by Sale Channels (2025-2030) & (USD Million)
 Table 147. North America Nocturia Consumption Value by Country (2019-2024) & (USD Million)
 Table 148. North America Nocturia Consumption Value by Country (2025-2030) & (USD Million)
 Table 149. Europe Nocturia Consumption Value by Type (2019-2024) & (USD Million)
 Table 150. Europe Nocturia Consumption Value by Type (2025-2030) & (USD Million)
 Table 151. Europe Nocturia Consumption Value by Sale Channels (2019-2024) & (USD Million)
 Table 152. Europe Nocturia Consumption Value by Sale Channels (2025-2030) & (USD Million)
 Table 153. Europe Nocturia Consumption Value by Country (2019-2024) & (USD Million)
 Table 154. Europe Nocturia Consumption Value by Country (2025-2030) & (USD Million)
 Table 155. Asia-Pacific Nocturia Consumption Value by Type (2019-2024) & (USD Million)
 Table 156. Asia-Pacific Nocturia Consumption Value by Type (2025-2030) & (USD Million)
 Table 157. Asia-Pacific Nocturia Consumption Value by Sale Channels (2019-2024) & (USD Million)
 Table 158. Asia-Pacific Nocturia Consumption Value by Sale Channels (2025-2030) & (USD Million)
 Table 159. Asia-Pacific Nocturia Consumption Value by Region (2019-2024) & (USD Million)
 Table 160. Asia-Pacific Nocturia Consumption Value by Region (2025-2030) & (USD Million)
 Table 161. South America Nocturia Consumption Value by Type (2019-2024) & (USD Million)
 Table 162. South America Nocturia Consumption Value by Type (2025-2030) & (USD Million)
 Table 163. South America Nocturia Consumption Value by Sale Channels (2019-2024) & (USD Million)
 Table 164. South America Nocturia Consumption Value by Sale Channels (2025-2030) & (USD Million)
 Table 165. South America Nocturia Consumption Value by Country (2019-2024) & (USD Million)
 Table 166. South America Nocturia Consumption Value by Country (2025-2030) & (USD Million)
 Table 167. Middle East & Africa Nocturia Consumption Value by Type (2019-2024) & (USD Million)
 Table 168. Middle East & Africa Nocturia Consumption Value by Type (2025-2030) & (USD Million)
 Table 169. Middle East & Africa Nocturia Consumption Value by Sale Channels (2019-2024) & (USD Million)
 Table 170. Middle East & Africa Nocturia Consumption Value by Sale Channels (2025-2030) & (USD Million)
 Table 171. Middle East & Africa Nocturia Consumption Value by Country (2019-2024) & (USD Million)
 Table 172. Middle East & Africa Nocturia Consumption Value by Country (2025-2030) & (USD Million)
 Table 173. Global Key Players of Nocturia Upstream (Raw Materials)
 Table 174. Global Nocturia Typical Customers


List of Figures
 Figure 1. Nocturia Picture
 Figure 2. Global Nocturia Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Nocturia Consumption Value Market Share by Type in 2023
 Figure 4. Desmopressin
 Figure 5. Anticholinergic Drugs
 Figure 6. Alpha Blockers
 Figure 7. Diuretics
 Figure 8. Others
 Figure 9. Global Nocturia Consumption Value by Sale Channels, (USD Million), 2019 & 2023 & 2030
 Figure 10. Nocturia Consumption Value Market Share by Sale Channels in 2023
 Figure 11. Hospital Pharmacies Picture
 Figure 12. Retail Pharmacies Picture
 Figure 13. Online Pharmacies Picture
 Figure 14. Global Nocturia Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 15. Global Nocturia Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 16. Global Market Nocturia Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 17. Global Nocturia Consumption Value Market Share by Region (2019-2030)
 Figure 18. Global Nocturia Consumption Value Market Share by Region in 2023
 Figure 19. North America Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 20. Europe Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 21. Asia-Pacific Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 22. South America Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 23. Middle East & Africa Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 24. Company Three Recent Developments and Future Plans
 Figure 25. Global Nocturia Revenue Share by Players in 2023
 Figure 26. Nocturia Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 27. Market Share of Nocturia by Player Revenue in 2023
 Figure 28. Top 3 Nocturia Players Market Share in 2023
 Figure 29. Top 6 Nocturia Players Market Share in 2023
 Figure 30. Global Nocturia Consumption Value Share by Type (2019-2024)
 Figure 31. Global Nocturia Market Share Forecast by Type (2025-2030)
 Figure 32. Global Nocturia Consumption Value Share by Sale Channels (2019-2024)
 Figure 33. Global Nocturia Market Share Forecast by Sale Channels (2025-2030)
 Figure 34. North America Nocturia Consumption Value Market Share by Type (2019-2030)
 Figure 35. North America Nocturia Consumption Value Market Share by Sale Channels (2019-2030)
 Figure 36. North America Nocturia Consumption Value Market Share by Country (2019-2030)
 Figure 37. United States Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 38. Canada Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 39. Mexico Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 40. Europe Nocturia Consumption Value Market Share by Type (2019-2030)
 Figure 41. Europe Nocturia Consumption Value Market Share by Sale Channels (2019-2030)
 Figure 42. Europe Nocturia Consumption Value Market Share by Country (2019-2030)
 Figure 43. Germany Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 44. France Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 45. United Kingdom Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 46. Russia Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 47. Italy Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 48. Asia-Pacific Nocturia Consumption Value Market Share by Type (2019-2030)
 Figure 49. Asia-Pacific Nocturia Consumption Value Market Share by Sale Channels (2019-2030)
 Figure 50. Asia-Pacific Nocturia Consumption Value Market Share by Region (2019-2030)
 Figure 51. China Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 52. Japan Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 53. South Korea Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 54. India Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 55. Southeast Asia Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 56. Australia Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 57. South America Nocturia Consumption Value Market Share by Type (2019-2030)
 Figure 58. South America Nocturia Consumption Value Market Share by Sale Channels (2019-2030)
 Figure 59. South America Nocturia Consumption Value Market Share by Country (2019-2030)
 Figure 60. Brazil Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 61. Argentina Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 62. Middle East & Africa Nocturia Consumption Value Market Share by Type (2019-2030)
 Figure 63. Middle East & Africa Nocturia Consumption Value Market Share by Sale Channels (2019-2030)
 Figure 64. Middle East & Africa Nocturia Consumption Value Market Share by Country (2019-2030)
 Figure 65. Turkey Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 66. Saudi Arabia Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 67. UAE Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 68. Nocturia Market Drivers
 Figure 69. Nocturia Market Restraints
 Figure 70. Nocturia Market Trends
 Figure 71. Porters Five Forces Analysis
 Figure 72. Nocturia Industrial Chain
 Figure 73. Methodology
 Figure 74. Research Process and Data Source

Companies Mentioned

Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Novartis
Johnson & Johnson
Merck
Astra Zeneca
Bristol-Myers Squibb
Hainan Zhonghe Pharmaceutical
Fosun Pharma
Hybio Pharmaceutical
Rechon Life Science AB
Zhejiang Conba Pharmaceutical
Chengdu Leer Pharmaceutical
Nanjing Xingyin Pharmaceutical Group
Sun Pharmaceutical Industries Ltd.
APOTEX INC
Sagent Pharmaceuticals